Medtronic received information that during the implant of this transcatheter bioprosthetic valve, before final release of the valve, an intravascular ultrasound (ivus) showed a left main trunk subtotal coronary occlusion.It was reported that the coronary occlusion was a result of the valve movement.The valve was deployed at a depth of 5 to 8 mm.Subsequently, a stent was placed successfully in the ostium of the left main coronary artery.It was believed that there was strong calcification in the valve apex that as blocked and contributed to the valve movement.No additional adverse patient effects were reported. .
|
Concomitant medical products: other relevant device(s) are: product id: d-evprop2329us, serial/lot #: (b)(4), ubd: 30-mar-2023, udi#: (b)(4), product analysis: the valve remains implanted and the delivery catheter system (dcs) was discarded, therefore no product analysis can be performed.Conclusion: without return of the products, no definitive conclusion can be made regarding the clinical observation.If information is provided in the future, a supplemental report will be issued.
|